CALCULATE YOUR SIP RETURNS

Stocks To Watch Today on April 15, 2025: Reliance Industries, Dr.Reddy’s, Sula Vineyards & More in Focus

Written by: Nikitha DeviUpdated on: Apr 15, 2025, 8:21 AM IST
Check out the stocks to watch on April 15, 2025, as they have made a significant announcement, which might affect their share price.
Stocks To Watch Today on April 15, 2025: Reliance Industries, Dr.Reddy’s, Sula Vineyards & More in Focus
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On Tuesday, April 15, 2025, the Indian benchmark indices Sensex and Nifty 50 are expected to open on a positive note, tracking a rally in global markets. Check out a few stocks that might be in focus during the trading session. 

Reliance Industries 

Nauyaan Tradings, a step-down wholly owned subsidiary of Reliance Industries, has acquired an additional 10% equity stake in Nauyaan Shipyard from Welspun Corp for ₹51.72 crore. Nauyaan Shipyard remains a step-down subsidiary of Reliance Industries. 

Tata Power 

Tata Power Renewable Energy, a subsidiary of Tata Power, has entered into a power purchase agreement (PPA) with NTPC to establish a 200 MW Firm and Dispatchable Renewable Energy Project. The project, valued at around ₹4,500 crore, is expected to be completed within 24 months. 

Sula Vineyards 

Sula Vineyards reported record-high revenue of ₹618.8 crore in FY25, marking a 1.7% increase from ₹608.7 crore in the previous fiscal year. In Q4 FY25, the company posted revenue of ₹132.6 crore, up 0.7% year-on-year. 

Ashoka Buildcon 

Ashoka Buildcon has emerged as the lowest bidder for a ₹568.86 crore gauge conversion project by Central Railway. The work covers earthwork, bridges, RUBs, P-way, and civil construction over a 53.3 km stretch between Pachora and Jamner. Completion is expected within 30 months. 

Zydus Lifesciences 

Zydus Lifesciences has received final approval from the US FDA to manufacture Jaythari (Deflazacort) Tablets in 6 mg, 18 mg, 30 mg, and 36 mg strengths. The medication is used in treating Duchenne muscular dystrophy (DMD) in patients aged 5 years and above 

Dr. Reddy’s Laboratories 

Dr. Reddy’s Laboratories has dismissed reports suggesting a 25% workforce reduction. It stated that the claims made in a recent news article are unfounded and confirmed that operations are continuing as usual. 

Conclusion 

Apart from these, several other stocks may remain in focus throughout the day due to market trends and company-specific developments. Keep an eye on key updates and market movements. 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Published on: Apr 15, 2025, 8:21 AM IST

Nikitha Devi

Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers